Trial Profile

Phase 3b, Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA Use in Pregnancy

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 29 Aug 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dapivirine (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
Indications HIV infections
Focus Adverse reactions; Therapeutic Use
Acronyms DELIVER

Most Recent Events

05 Jul 2024 Status changed from active, no longer recruiting to completed.
06 Mar 2024 Results from the 3rd cohort of women initiating product during the 2nd trimester of pregnancy, presented at the 31st Conference on Retroviruses and Opportunistic Infections 2024.
27 Sep 2023 Results of safety from first two cohorts of pregnant participants, published in the JAIDS

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com